TriangleNab paclitaxel (NCT06576115)
Nab paclitaxel trial for Metastatic Pancreatic Adenocarcinoma (NCT06576115). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for adults over 18 with metastatic pancreatic adenocarcinoma and measurable disease. Recent gemcitabine or nab-paclitaxel around surgery and known brain metastases are excluded.
The idea: researchers add the TheraBionic P1 device to gemcitabine and nab-paclitaxel chemotherapy. A spoon-shaped antenna in the mouth delivers low-level radio waves for one hour, three times daily. Chemotherapy is given by infusion on scheduled days. The study tests six-month progression-free survival and safety; it does not compare randomized groups.
This phase 2 study plans 30 patients. Anthony Shields leads at Karmanos; seven US sites recruit.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.